Sanofi and Verily form joint venture to Personalise Diabetes Care

By Jasmine Kalsi

Pharma Deals Review: Vol 2016 Issue 9 (Table of Contents)

Published: 27 Sep-2016

DOI: 10.3833/pdr.v2016.i9.2196     ISSN: 1756-7874

Section: Joint Venture

Fulltext:

Abstract

Expanding its diabetes offerings, Sanofi has entered into an agreement with Verily Life Sciences, the healthcare unit of Alphabet - Google’s parent company - to form a joint venture called Onduo to develop devices, software and drugs to assist in patient management of diabetes...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

PharmaDeals has now moved to a new platform (https://analyticslink.customerportal.iqvia.com). The current PharmaDeals website will be disabled from October 31, 2026. Please update your bookmarks and, if you have any issues accessing the new platform, please contact your IQVIA account manager.

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details